Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 4-oxo-3,4-dihydroquinazoline compounds as inhibitors of human immunodeficiency virus replication

4-oxo-3,4-dihydroquinazoline compounds as inhibitors of human immunodeficiency virus replication

US Patent 11505543 · Granted Nov 22, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for blocking sodium channels2025
Potent ASGPR-binding compounds for the degradation of immunoglobulins and other 2025
ASGPR-binding compounds for the degradation of extracellular proteins2025
ASGPR-binding compounds for the degradation of extracellular proteins2025
ASGPR-binding compounds for the degradation of extracellular proteins2024
Pyrido [2,3-d]pyrimidine derivatives as inhibitors of human immunodeficiency vir2024
Pyrido [2,3-d]pyrimidine derivatives as inhibitors of human immunodeficiency vir2024
Triazolopyridinyl compounds as kinase inhibitors2024
Potent ASGPR-binding compounds for the degradation of immunoglobulins and other 2024
ASGPR-binding compounds for the degradation of extracellular proteins2024
Inhibitors of human immunodeficiency virus replication2024
Inhibitors of human immunodeficiency virus replication2024